The potential ability to suppress CYP1A1 or inhibit intestinal cadaverine-HRH4 signaling to enhance IEC junctions, or a combination of these two strategies, warrants further study to develop more effective sepsis treatment. This evidence concerns the gene HRH4 and Sepsis.